Federated Hermes
ORGO icon

Federated Hermes’s Organogenesis Holdings ORGO Stock Holding History

Federated Hermes’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-374
Closed -$886 – 2141
2026
Q1 		$886 Sell
374
-8,167
-96% -$28.3K ﹤0.01% 2007
2025
Q4 		$44.2K Buy
8,541
+2,953
+53% +$14.3K ﹤0.01% 1653
2025
Q3 		$23.6K Buy
5,588
+1,883
+51% +$8.75K ﹤0.01% 1784
2025
Q2 		$13.6K Buy
3,705
+1,309
+55% +$4.88K ﹤0.01% 1769
2025
Q1 		$10.4K Buy
2,396
+285
+14% +$1.15K ﹤0.01% 1799
2024
Q4 		$6.75K Buy
2,111
+503
+31% +$1.69K ﹤0.01% 1873
2024
Q3 		$4.6K Buy
1,608
+161
+11% +$452 ﹤0.01% 1867
2024
Q2 		$4.05K Sell
1,447
-9,243
-86% -$24.8K ﹤0.01% 1861
2024
Q1 		$30.4K Sell
10,690
-975
-8% -$3.31K ﹤0.01% 1677
2023
Q4 		$47.7K Sell
11,665
-112,939
-91% -$316K ﹤0.01% 1655
2023
Q3 		$396K Sell
124,604
-100,081
-45% -$318K ﹤0.01% 1404
2023
Q2 		$746K Sell
224,685
-1,670,231
-88% -$4.94M ﹤0.01% 1239
2023
Q1 		$4.04M Sell
1,894,916
-998,694
-35% -$2.47M 0.01% 755
2022
Q4 		$7.78M Buy
2,893,610
+292,666
+11% +$854K 0.02% 600
2022
Q3 		$8.43M Buy
2,600,944
+8,932
+0.3% +$40.4K 0.02% 566
2022
Q2 		$12.6M Buy
2,592,012
+1,561,269
+151% +$9.61M 0.03% 499
2022
Q1 		$7.85M Buy
1,030,743
+943,875
+1,087% +$7.31M 0.02% 666
2021
Q4 		$802K Buy
86,868
+41,162
+90% +$437K ﹤0.01% 1357
2021
Q3 		$651K Sell
45,706
-162,854
-78% -$2.53M ﹤0.01% 1431
2021
Q2 		$3.47M Sell
208,560
-385,190
-65% -$7.18M 0.01% 937
2021
Q1 		$10.8M Buy
593,750
+583,344
+5,606% +$7.9M 0.02% 644
2020
Q4 		$78K Buy
10,406
+4,648
+81% +$22.1K ﹤0.01% 1770
2020
Q3 		$22K Sell
5,758
-163
-3% -$644 ﹤0.01% 1883
2020
Q2 		$23K Sell
5,921
-369
-6% -$1.33K ﹤0.01% 1848
2020
Q1 		$20K Buy
+6,290
New +$26.9K ﹤0.01% 1790
2019
Q4 		– Sell
-3,102
Closed -$20K – 2279
2019
Q3 		$20K Buy
+3,102
New +$17.3K ﹤0.01% 1827

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Federated Hermes's ORGO Position: Q2 2026 in Review

Federated Hermes sold out of Organogenesis Holdings (ORGO) in Q2 2026, closing a stake of 374 shares — an estimated $886 sold.

Federated Hermes first reported a position in ORGO in Q3 2019 and held it in 26 quarters. The position peaked at $12.6M in Q2 2022. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Federated Hermes reported no remaining Organogenesis Holdings position as of Q2 2026 after selling out during the quarter.
  • Federated Hermes sold 374 Organogenesis Holdings shares in Q2 2026, an estimated $886.
  • Federated Hermes first reported a position in Organogenesis Holdings in Q3 2019 and held it in 26 quarters.
  • Federated Hermes's Organogenesis Holdings position peaked at $12.6M in Q2 2022.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.